Literature DB >> 20139287

Combination therapy with verteporfin and anti-VEGF agents in neovascular age-related macular degeneration: where do we stand?

Peter K Kaiser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20139287     DOI： 10.1136/bjo.2009.159863

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  8 in total

Review 1.  [Pigment epithelial detachment in exudative macular degeneration: clinical characteristics and therapeutic options].

Authors:  A Lommatzsch
Journal:  Ophthalmologe       Date:  2010-12       Impact factor: 1.059

Review 2.  Treatment of age-related macular degeneration: beyond VEGF.

Authors:  Joan W Miller
Journal:  Jpn J Ophthalmol       Date:  2010-12-30       Impact factor: 2.447

3.  Angiography with a multifunctional line scanning ophthalmoscope.

Authors:  Daniel X Hammer; R Daniel Ferguson; Ankit H Patel; Vanessa Vazquez; Deeba Husain
Journal:  J Biomed Opt       Date:  2012-02       Impact factor: 3.170

4.  Single-session photodynamic therapy combined with intravitreal ranibizumab for neovascular age-related macular degeneration: a comprehensive functional retinal assessment.

Authors:  Mariacristina Parravano; Vincenzo Parisi; Lucia Ziccardi; Adele Chiaravalloti; Massimiliano Tedeschi; Andrea Cacciamani; Barbara Boccassini; Antonluca Boninfante; Monica Varano
Journal:  Doc Ophthalmol       Date:  2013-08-13       Impact factor: 2.379

5.  Assessment of differential pharmacodynamic effects using optical coherence tomography in neovascular age-related macular degeneration.

Authors:  Pearse A Keane; Florian M Heussen; Yanling Ouyang; Nils Mokwa; Alexander C Walsh; Adnan Tufail; Srinivas R Sadda; Praveen J Patel
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

6.  Management of neovascular age-related macular degeneration in clinical practice: initiation, maintenance, and discontinuation of therapy.

Authors:  Pearse A Keane; Adnan Tufail; Praveen J Patel
Journal:  J Ophthalmol       Date:  2011-11-22       Impact factor: 1.909

7.  Development of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians.

Authors:  Pearse A Keane; Srinivas R Sadda
Journal:  J Ophthalmol       Date:  2011-12-18       Impact factor: 1.909

8.  EFFICACY AND SAFETY OF RANIBIZUMAB FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO UNCOMMON CAUSE: Twelve-Month Results of the MINERVA Study.

Authors:  Timothy Y Y Lai; Giovanni Staurenghi; Paolo Lanzetta; Frank G Holz; Shiao Hui Melissa Liew; Sabine Desset-Brethes; Harry Staines; Philip G Hykin
Journal:  Retina       Date:  2018-08       Impact factor: 4.256
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.